MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Botulinum toxin in Restless Leg Syndrome – A Randomized Double-Blind Placebo-Controlled Study

    S. Mittal, D. Machado, D. RIchardson, D. Dubey, B. Jabbari (Bangalore, India)

    Objective: To study the efficacy of incobotulinumtoxin A (IncoA) in relieving the symptoms of restless legs syndrome (RLS) Background: RLS is a common movement disorder…
  • 2018 International Congress

    Restless Legs Syndrome in Pregnant Thai Women: Prevalence, Natural History, and Risk Factors

    S. Panvatvanich, P. Lolekha (Pathumthani, Thailand)

    Objective: This study was aimed to estimate the prevalence, natural history, and associated factors of Restless legs syndrome in pregnant Thai women. Background: Restless legs…
  • 2018 International Congress

    The prevalence of restless legs syndrome in Edirne and its districts concomitant comorbid conditions and secondary complications

    S. Güler, A. Caylan, F. Turan (Edirne, Turkey)

    Objective: We aimed to determine the prevalence and risk factors of restless legs syndrome in Edirne and its districts, located in Western Thrace, which is…
  • 2018 International Congress

    Difference in sleep disorders among Parkinson’s disease, cervical dystonia and patients with depression

    S. Tomic, D. Degmecic, S. Milanovic, F. Gjoni, I. Dumencic, Z. Popovic, T. Gilman Kuric (Osijek, Croatia)

    Objective: Aim of this study was to evaluate frequency and characteristics of sleep disorders among patients with Parkinson disease (PD), cervical dystonia (CD) and depression.…
  • 2018 International Congress

    Neurostructural alterations associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s disease

    C. Beal, V. Planche, C. Chassain, A. Marques, J.M. Bonny, B. Pereira, N. Vitello, M.L. Fantini, F. Durif (Clermont-Ferrand, France)

    Objective: The aim of current study was to evaluate the volumetry of subcortical structures in Parkinson's disease (PD) patients with Rapid Eye Movement (REM) Sleep…
  • 2018 International Congress

    Seasonal Fluctuation in a Chinese cohort of patients with idiopathic Restless Legs Syndrome

    XY. Zhu, LY. Ni, Y. Liu, XJ. Zhang, WH. Yang, YC. Wu (Shanghai, China)

    Objective: To evaluate incidence and characteristics of seasonal fluctuation in a Chinese cohort of patients with idiopathic RLS in order to differentiate possible subtypes and…
  • 2018 International Congress

    “Appropriate Doses Treatment” of IncobotulinumtoxinA in spasticity

    G. Ianieri, R. Marvulli (Bari, Italy)

    Objective: The aim of this study is to object the efficiency and safety of 100 to 1000 units botulinum toxin treatment with modulation of spasticity…
  • 2018 International Congress

    Analysis of the electromyographic profile of a subject with spasticity during the lateral reactive postural control test

    M. Maldonado (Santiago, Chile)

    Objective: To compare the temporal profile and the level of muscular activity of a subject with Stroke and a healthy subject, as well as to…
  • 2018 International Congress

    Evaluation of Effectiveness and Safety of Botulinum Toxin Type-A (BTX-A) for Chronic Focal Post-Stroke Upper Limb Spasticity in Indian Stroke Patients

    L. Basumatary (Guwahati, India)

    Objective: To evaluate the effectiveness and safety of Botulinum Toxin Type-A (BTX-A) for the treatment chronic focal post-stroke upper limb spasticity in Indian stroke patients.…
  • 2018 International Congress

    Intrathecal baclofen (ITB) therapy in the treatment of severe spasticity: Safety and Product Performance from a Large Multinational Multi-Center Registry

    M. Schiess, S. Eldabe, R. Spencer, K. Stromberg, T. Weaver, R. Plunkett (Houston, TX, USA)

    Objective: •To use real-world registry data to augment available safety data, product performance and support overall efficacy. •To utilize registry data to broaden awareness of…
  • « Previous Page
  • 1
  • …
  • 1119
  • 1120
  • 1121
  • 1122
  • 1123
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #25676 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Welcome to the MDS Abstracts Site
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley